IMUX - Immunic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5146.05M
Enterprise Value 3107.47M
Trailing P/E N/A
Forward P/E 1-5.21
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)N/A
Price/Book (mrq)2.08
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-5.79

Trading Information

Stock Price History

Beta (3Y Monthly) 2.49
52-Week Change 3-18.24%
S&P500 52-Week Change 33.55%
52 Week High 346.80
52 Week Low 36.04
50-Day Moving Average 313.92
200-Day Moving Average 312.59

Share Statistics

Avg Vol (3 month) 3151.21k
Avg Vol (10 day) 356.1k
Shares Outstanding 510.09M
Float 2.35M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug 15, 2019) 445.44k
Short Ratio (Aug 15, 2019) 40.78
Short % of Float (Aug 15, 2019) 40.96%
Short % of Shares Outstanding (Aug 15, 2019) 40.45%
Shares Short (prior month Jul 15, 2019) 497.44k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 240/1
Last Split Date 3Apr 15, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.57M
Net Income Avi to Common (ttm)-25.64M
Diluted EPS (ttm)-11.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.12M
Total Cash Per Share (mrq)3.58
Total Debt (mrq)66k
Total Debt/Equity (mrq)0.09
Current Ratio (mrq)12.65
Book Value Per Share (mrq)6.95

Cash Flow Statement

Operating Cash Flow (ttm)-21.83M
Levered Free Cash Flow (ttm)N/A